Business
Strata Critical Medical Announces Third Quarter 2025 Results
Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to
About this update from Strata Critical Medical, Inc.
[{"type":"text","content":"Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to $(9.7) million in Q3 2025 versus $(5.6) million in the prior year periodMedical Segment Adjusted EBITDA increased 93.5% in Q3 2025 to $7.6 million versus the prior year period and increased 80.2% excluding the impact of the Keystone acquisition(1)Medical Segment Adjusted EBITDA margin excluding Keystone increased to 15.1% in Q3 2025(1)Raised 2025 revenue guidance to $185-195 million, reaffirmed Adjusted EBITDA rangeInvestor Day scheduled for November 17th 2025; will introduce 2026 guidance and medium term financial targets NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, \"Strata\" or the \"Company\"), today announced financial results for the third quarter ended September 30, 2025. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Blade Passenger business have been reclassified as discontinued operations in all periods. GAAP FINANCIAL RESULTS(in thousands except percentages, unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 % Change 2025 2024 % Change Revenue$49,298 $36,062 36.7 % $130,354 $110,429 18.0 % Cost of revenue$37,684 $28,554 32.0 % $100,898 $85,854 17.5 % Software development 453 417 8.6 % 1,354 1,031 31.3 % General and administrative 16,301 13,869 17.5 % 42,954 39,140 9.7 % Selling and marketing 482 314 53.5 % 1,096 1,025 6.9 % Total operating expenses$54,920 $43,154 27.3 % $146,302 $127,050 15.2 % Net loss from continuing operations$(9,657) $(5,627) 71.6 % $(14,678) $(8,731) 68.1 % Gross profit$9,545 $5,427 75.9 % $23,198 $19,624 18.2 % Gross margin 19.4 % 15.0 % 440bps 17.8 % 17.8 % —bps NON-GAAP(1) FINANCIAL RESULTS(in thousands except percentages, unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 % Change 2025 2024 % ChangeRevenue$49,298 $36,062 36.7 % $130,354 $110,429 18.0 %Cost of revenue 37,684 28,554 32.0 % 100,898 85,854 17.5 %Flight Profit 11,614 7,508 54.7 % 29,456 24,575 19.9 %Flight Margin 23.6 % 20.8 % 280bps 22.6 % 22.3 % 30bps Adjusted EBITDA$4,214 $67 6,189.6 % $7,096 $2,677 165.1 %% of Revenue 8.5 % 0.2 % 830bps 5.4 % 2.4 % 300bps Adjusted u...